Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder COVID-Associated Exacerbation of Acute Psychosis in a Patient With Schizoaffective Disorder PDF $40.00
$40.00
× Placeholder Antipsychotic Medication and Oxidative Cell Stress: A Systematic Review PDF $40.00
$40.00
× Placeholder Suicide Attempts and Ideation in Patients With Bipolar I Disorder PDF $40.00
$40.00
× Placeholder A Critical Appraisal of Treatments for Bipolar Disorder PDF $40.00
$40.00
× Placeholder Preventive Cognitive Therapy With Antidepressant Discontinuation During Pregnancy: Results From a Randomized Controlled Trial PDF $0.00
$0.00
× Placeholder Using Dialectical Behavior Therapy to Treat Misophonia in Adolescence PDF $40.00
$40.00
× Placeholder The Course of Eating Disorders During COVID-19 PDF $40.00
$40.00
× Placeholder A Qualitative Study on Stigmatization Associated With COVID-19 PDF $40.00
$40.00
× Placeholder A Randomized Controlled Trial of Fluvoxamine in Prostatodynia, a Male Somatoform Pain Disorder PDF $40.00
$40.00
× Placeholder Psychometrics of the Violence Nonlinear Dynamics Scale PDF $40.00
$40.00
× Placeholder Comorbidity and Quality of Life in DSM-5 Social Anxiety Disorder Among a Nationally Representative Sample PDF $40.00
$40.00
× Placeholder Impact of CYP1A2 and CYP2D6 Polymorphisms on Drug Metabolism and on Insulin and Lipid Elevations and Insulin Resistance in Clozapine-Treated Patients PDF $40.00
$40.00
× Placeholder Effects of Olanzapine on Prolactin Levels of Female Patients With Schizophrenia Treated With Risperidone PDF $40.00
$40.00
× Placeholder Psychocutaneous Medicine in Iraq: Current Status and Recommendations PDF $40.00
$40.00
× Placeholder Predictors for Initiation of Atypical Long-Acting Injectable Antipsychotic Agents in a Commercial Claims Cohort of Individuals With Early-Phase Schizophrenia PDF $40.00
$40.00
× Placeholder The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases PDF $40.00
$40.00
× Placeholder Methylphenidate Treatment for Cocaine Abusers With Adult Attention-Deficit/Hyperactivity Disorder: A Pilot Study PDF $40.00
$40.00
× Placeholder Reduction of Opioid-Withdrawal Symptoms With Quetiapine PDF $40.00
$40.00
× Placeholder Therapeutic Response Is Associated With Antipsychotic-Induced Weight Gain in Drug-Naive First-Episode Patients With Schizophrenia: An 8-Week Prospective Study PDF $40.00
$40.00
× Placeholder Correlates and Variation in Early Maladaptive Schema Domains Between Day 1 and Day 15 of Menses Among Lebanese Female University Students PDF $40.00
$40.00
× Placeholder Topiramate Treatment for SSRI-Induced Weight Gain in Anxiety Disorders PDF $40.00
$40.00
× Placeholder Treatment Nonadherence and Neurocognitive Impairment in Bipolar Disorder PDF $40.00
$40.00
× Placeholder Meta-Analysis of Suicidality in Placebo-Controlled Clinical Trials of Adults Taking Bupropion PDF $40.00
$40.00
× Placeholder The Co-occurrence of Gastrointestinal Symptoms and Psychosis: Diagnostic Considerations PDF $0.00
$0.00
× Placeholder Long-Term Safety and Efficacy of Esmethadone in Patients With Major Depressive Disorder: Findings From a 12-Month Open-Label Study PDF $40.00
$40.00
× Placeholder Early Improvement Under Mirtazapine and Paroxetine Predicts Later Stable Response and Remission With High Sensitivity in Patients With Major Depression PDF $40.00
$40.00
× Placeholder Use of Face Masks Among Patients With Psychiatric Illnesses During the COVID-19 Pandemic: A Hospital-Based Cross-Sectional Study PDF $40.00
$40.00
× Placeholder Clinical Characteristics of Bipolar vs. Unipolar Depression in Preschool Children: An Empirical Investigation PDF $40.00
$40.00
× Placeholder Trauma and Stress: Diagnosis and Treatment. PDF $40.00
$40.00
× Placeholder Selective Serotonin Reuptake Inhibitor (SSRI) Add-On Therapy for the Negative Symptoms of Schizophrenia: A Meta-Analysis PDF $40.00
$40.00
× Placeholder Googling Suicide: Surfing for Suicide Information on the Internet PDF $40.00
$40.00
× Placeholder Satisfaction With Medication Is Correlated With Outcome but Not Persistence in Patients Treated With Placebo, Escitalopram, or Serotonin-Norepinephrine Reuptake Inhibitors: A Post Hoc Analysis PDF $40.00
$40.00
× Placeholder Childhood Stimulant Treatment and Risk for Later Substance Abuse PDF $0.00
$0.00
× Placeholder Faces Scales for Anxiety and Anger: A National Study of Measurement Properties PDF $40.00
$40.00
× Placeholder Patient Compliance to a New Enteric-Coated Weekly Formulation of Fluoxetine During Continuation Treatment of Major Depressive Disorder PDF $40.00
$40.00
× Placeholder Role of Minocycline as an Adjunct Neuroinflammatory Modulator in Treatment-Resistant Depression: A Systematic Review of Randomized Controlled Trials PDF $40.00
$40.00
× Placeholder “Cocaine Bugs”: Implications for Primary Care Providers PDF $40.00
$40.00
× Placeholder Agomelatine Prevents Relapse in Generalized Anxiety Disorder: A 6-Month Randomized, Double-Blind, Placebo-Controlled Discontinuation Study PDF $40.00
$40.00
× Placeholder A Novel Therapy for Chronic Sleep-Onset Insomnia: A Retrospective, Nonrandomized Controlled Study of Auto-Adjusting, Dual-Level, Positive Airway Pressure Technology PDF $40.00
$40.00
× Placeholder Joy Journal: A Behavioral Activation Technique Used in the Treatment of Late-Life Depression Associated With Hopelessness During the COVID-19 Pandemic PDF $40.00
$40.00
× Placeholder Differences in Prescription Stimulant Misuse Motives Across Adolescents and Young Adults in the United States PDF $40.00
$40.00
× Placeholder Outcome of a 4-Step Treatment Algorithm for Depressed Inpatients PDF $40.00
$40.00
× Placeholder Venlafaxine in Dysthymic Disorder PDF $40.00
$40.00
× Placeholder Management of ADHD in Adults PDF $0.00
$0.00
× Placeholder The Selective GABA Reuptake Inhibitor Tiagabine for the Treatment of Generalized Anxiety Disorder: Results of a Placebo-Controlled Study PDF $40.00
$40.00
× Placeholder Lamotrigine Rechallenge in Treatment-Resistant Bipolar Disorder PDF $40.00
$40.00
× Placeholder The Resolution of Eczema During Treatment With Lamotrigine: A Case Report PDF $40.00
$40.00
× Placeholder The Safety of Olanzapine in Adolescents With Schizophrenia or Bipolar I Disorder: A Pooled Analysis of 4 Clinical Trials PDF $40.00
$40.00
× Placeholder Reconsidering Insomnia as a Disorder Rather Than Just a Symptom in Psychiatric Practice PDF $0.00
$0.00
× Placeholder A Cluster of Cholesterol-Related Genes Confers Susceptibility for Alzheimer's Disease PDF $40.00
$40.00
× Placeholder Effect of Second-Generation Antipsychotics on Caregiver Burden in Alzheimer's Disease PDF $40.00
$40.00
× Placeholder The Impact of Depression on Asthma Episodes in the US Population PDF $40.00
$40.00
× Placeholder Increased Silent Brain Infarction Accompanied With High Prevalence of Diabetes and Dyslipidemia in Psychiatric Inpatients: A Cross-Sectional Study PDF $40.00
$40.00
× Placeholder Zoom Dysmorphia and Body Dysmorphic Disorder: Regarding Technology Use in Psychiatry and Mental Health PDF $40.00
$40.00
× Placeholder Assessment of Treatment Algorithms Including Amantadine, Metformin, and Zonisamide for the Prevention of Weight Gain With Olanzapine: A Randomized Controlled Open-Label Study PDF $40.00
$40.00
× Placeholder Treatment With Phytoestrogens for Depressive Symptoms in Late-Onset Schizophrenia: A Case Report PDF $40.00
$40.00
× Placeholder Prevalence of Obsessive-Compulsive Disorder in Patients With Systemic Lupus Erythematosus PDF $40.00
$40.00
× Placeholder Screening Physical or Sexual Abuse Victims for Substance Abuse PDF $40.00
$40.00
× Placeholder Quantitative Electroencephalogram Biomarkers for Predicting Likelihood and Speed of Achieving Sustained Remission in Major Depression: A Report From the Biomarkers for Rapid Identification of Treatment Effectiveness in Major Depression (BRITE-MD) Trial PDF $40.00
$40.00
× Placeholder Incentive Sensitivity as a Behavioral Marker of Clinical Remission From Major Depressive Episode PDF $40.00
$40.00
× Placeholder Effects of Electroconvulsive Therapy on Functional Outcomes Among Medicare Patients With Comorbid Depression and Dementia: A Nationwide 1-Year Follow-Up Study PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $2,240.00
Total $2,240.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe